Benidipine hydrochloride

CAS No. 91599-74-5

Benidipine hydrochloride( (±)-Benidipine | KW-3049 )

Catalog No. M16577 CAS No. 91599-74-5

Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 34 Get Quote
50MG 45 Get Quote
100MG 63 Get Quote
200MG 105 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Benidipine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
  • Description
    Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.
  • In Vitro
    Western Blot Analysis Cell Line:Murine PBMCs Concentration:1 μM Incubation Time:7 days Result:Increased the expression of phosphorylated Akt on serine-473.Cell Proliferation Assay Cell Line:Mesangial cells Concentration:0.1-10 μM Incubation Time:48 h Result:Inhibited the progression of the cell cycle in a dose-dependent manner.
  • In Vivo
    Animal Model:MI/R rabbits model Dosage: 3-10 μg/kg Administration:i.v.Result:Caused a significant decrease in HR ( heart rate), MABP (mean arterial blood pressure), and PRI (pressure-rate index) at 10 μg/kg.Decreased apoptotic positive cells to 7.4% at 3 μg/kg.Animal Model:Renovascular hypertensive rats (RHR) model Dosage:5 mg/kg Administration:i.v.Result:Decreased the blood pressure and coronary vascular resistance index.Increased nitrite production and eNOS mRNA expression and the coronary flow at rest, the capillary density.Animal Model:Rat heart model Dosage:1-10 mg/kg Administration:p.o.Result:Increased the post-ischemic recovery of LVDP and LV dP/dt max (LVDP: 87.5±10.1 vs 64.6±11.9%;LV dP/dt max: 97.8±10.4 vs 70.2±15.7%) at 3 mg/kg.
  • Synonyms
    (±)-Benidipine | KW-3049
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR (L861Q)| c-Src| c-Yes| Lck| Lyn
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    91599-74-5
  • Formula Weight
    542.03
  • Molecular Formula
    C27H32ClN5O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 8 mg/mL (14.75 mM)
  • SMILES
    CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chang YM, Oncogene, 2008, 27(49), 6365-6375.
molnova catalog
related products
  • Labuxtinib

    Labutinib is a selective inhibitor of the c-kit tyrosine kinase .

  • JCN037

    JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of 2.49 nM, 3.95 nM, 4.48 nM , respectively).

  • LDC4297

    LDC4297 is a potent and selective CDK7 inhibitor.